John Winder

Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis

Clinical Therapeutics · 1996 · 13 citations

A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma

Journal of Allergy and Clinical Immunology · 1998 · Last of 6 authors · 9 citations